- Presentations
- 5
- Markets
- 1
Otezla is a brand of Apremilast marketed by Amgen, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Apremilast
- Brand owner
- Amgen
- Registered in
- United States
- Strengths and forms
- kit, 20 mg tablet, 30 mg tablet, 75 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Otezla kit | Amgen | US FDA | Available on request |
| Otezla kit | Amgen | US FDA | Available on request |
| Otezla 20 mg tabletOral | Amgen | US FDA | Available on request |
| Otezla 30 mg tabletOral | Amgen | US FDA | Available on request |
| Otezla 75 mg tabletOral | Amgen | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Otezla
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.